longterm tobramycin therapi patient cystic fibrosi advanc pulmonari diseas aim clinic studi wa find prolong tobramycin therapi prevent rapid deterior cystic fibrosi patient eleven cours treatment given nine patient eight markedli improv physic activ gain weight howev onli four patient wa clinic improv correl improv radiogram pseudomona wa erad sputum onli four patient dure therapi reappear three befor end therapi clinic improv neglig side effect suggest treatment exacerb pyocyaneu bronchopneumonia prolong tobramycin therapi dosag higher 5 mgkgday strict control tobramycin blood level awar side effect